BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21288959)

  • 1. Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study.
    Provan SA; Semb AG; Hisdal J; Stranden E; Agewall S; Dagfinrud H; Angel K; Atar D; Kvien TK
    Ann Rheum Dis; 2011 May; 70(5):812-7. PubMed ID: 21288959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study.
    Klarenbeek NB; van der Kooij SM; Güler-Yüksel M; van Groenendael JH; Han KH; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2011 Feb; 70(2):315-9. PubMed ID: 21068104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis.
    van Tuyl LH; Lems WF; Kerstens PJ; Voskuyl AE; Dijkmans BA; Boers M
    Ann Rheum Dis; 2009 Oct; 68(10):1652-3. PubMed ID: 19748920
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis.
    Metsios GS; Stavropoulos-Kalinoglou A; Panoulas VF; Wilson M; Nevill AM; Koutedakis Y; Kitas GD
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):188-94. PubMed ID: 19238083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a prediction rule for development of rheumatoid arthritis in patients with early undifferentiated arthritis.
    Kuriya B; Cheng CK; Chen HM; Bykerk VP
    Ann Rheum Dis; 2009 Sep; 68(9):1482-5. PubMed ID: 19015211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of functional impairment and remission in rheumatoid arthritis patients by biochemical variables and genetic polymorphisms.
    Balsa A; Del Amo J; Blanco F; Caliz R; Silva L; Sanmarti R; Martínez FG; Tejedor D; Artieda M; Pascual-Salcedo D; Oreiro N; Collado MD; Andreu JL; Graell E; Simón L; Martínez A; Mulero J
    Rheumatology (Oxford); 2010 Mar; 49(3):458-66. PubMed ID: 20032229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
    Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
    Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk in rheumatoid arthritis.
    Nurmohamed MT
    Autoimmun Rev; 2009 Jul; 8(8):663-7. PubMed ID: 19393192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions.
    Sanders S; Geraci SA
    J Miss State Med Assoc; 2010 Mar; 51(3):75-80. PubMed ID: 20827876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rheumatoid arthritis (updated Current Care guideline)].
    Hakala M; Hannonen P; Helve T; Korpela M; Mattila K; Möttönen T; Varis T;
    Duodecim; 2009; 125(19):2131-2. PubMed ID: 19938416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum uric acid with cardiovascular disease in rheumatoid arthritis.
    Panoulas VF; Milionis HJ; Douglas KM; Nightingale P; Kita MD; Klocke R; Elisaf MS; Kitas GD
    Rheumatology (Oxford); 2007 Sep; 46(9):1466-70. PubMed ID: 17644822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
    J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation.
    van Halm VP; Peters MJ; Voskuyl AE; Boers M; Lems WF; Visser M; Stehouwer CD; Spijkerman AM; Dekker JM; Nijpels G; Heine RJ; Bouter LM; Smulders YM; Dijkmans BA; Nurmohamed MT
    Ann Rheum Dis; 2009 Sep; 68(9):1395-400. PubMed ID: 18697775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis.
    van Halm VP; Slot MC; Nurmohamed MT; Tervaert JW; Dijkmans BA; Voskuyl AE
    Ann Rheum Dis; 2006 May; 65(5):590-4. PubMed ID: 16249230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis.
    Giles JT; Post W; Blumenthal RS; Bathon JM
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):320-9. PubMed ID: 16932711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis.
    Cleland LG; Caughey GE; James MJ; Proudman SM
    J Rheumatol; 2006 Oct; 33(10):1973-9. PubMed ID: 16881100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk factors in women with and without rheumatoid arthritis.
    Solomon DH; Curhan GC; Rimm EB; Cannuscio CC; Karlson EW
    Arthritis Rheum; 2004 Nov; 50(11):3444-9. PubMed ID: 15529391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis.
    Quartuccio L; Fabris M; Salvin S; Atzeni F; Saracco M; Benucci M; Cimmino M; Morassi P; Masolini P; Pellerito R; Cutolo M; Puttini PS; De Vita S
    Rheumatology (Oxford); 2009 Dec; 48(12):1557-9. PubMed ID: 19789202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis.
    García-Gómez C; Nolla JM; Valverde J; Gómez-Gerique JA; Castro MJ; Pintó X
    J Rheumatol; 2009 Jul; 36(7):1365-70. PubMed ID: 19369465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.